Literature DB >> 17391355

Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.

Gin S Malhi1, Belinda Ivanovski, Dusan Hadzi-Pavlovic, Philip B Mitchell, Eduard Vieta, Perminder Sachdev.   

Abstract

OBJECTIVE: To examine whether patients with bipolar disorder (BD) have subtle neuropsychological deficits that manifest clinically as cognitive and functional compromise, and this study attempted to determine the pattern of such cognitive deficits and their functional impact across all three phases of BD. We hypothesised that euthymia does not equate with normal neuropsychological function and that each phase has a characteristic pattern of deficits, with disturbance in attention and memory being common across all phases of the illness: (i) bipolar depression - psychomotor slowing and impairment of memory; (ii) hypomania by frontal-executive deficits and (iii) euthymia - a mild disturbance of attention, memory and executive function.
METHODS: Twenty-five patients with a diagnosis of bipolar I disorder underwent neuropsychological testing over a period of 30 months in the natural course of their illness while hypomanic and/or depressed and/or euthymic. The results from these assessments were compared with findings from neuropsychological tests conducted on 25 healthy controls matched for age, sex, education and handedness.
RESULTS: Initial analyses revealed modest impairment in executive functioning, memory and attention in both hypomanic and depressed bipolar patients, with additional fine motor skills impairment in the latter. Memory deficits, also noted in euthymic patients, were non-significant after controlling for confounding variables, although bipolar depressed patients remained significantly impaired on tests of verbal recall. Bipolar depressed and hypomanic patients differed with respect to the nature of their memory impairment. Depressed patients were more impaired as compared with euthymic patients on tests of verbal recall and fine motor skills. Psychosocial functioning was impaired across all three patient groups, but only in depressed and hypomanic patients did this correlate significantly with neuropsychological performance.
CONCLUSIONS: The mood-state-related cognitive deficits in both bipolar depression and hypomania compromise psychosocial function when patients are unwell. In euthymic patients, subtle impairments in attention and memory suggest that an absence of symptoms does not necessarily equate to 'recovery'. The possibility of persistent cognitive deficits in BD is an issue of profound clinical and research interest that warrants further investigation; however, future research needs to adopt more sophisticated neuropsychological probes that are able to better define state and trait deficits and determine their functional impact.

Entities:  

Mesh:

Year:  2007        PMID: 17391355     DOI: 10.1111/j.1399-5618.2007.00324.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  80 in total

1.  Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders.

Authors:  Olga Rass; Giri Krishnan; Colleen A Brenner; William P Hetrick; Colleen C Merrill; Anantha Shekhar; Brian F O'Donnell
Journal:  Bipolar Disord       Date:  2010-12       Impact factor: 6.744

2.  Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Joseph F Goldberg
Journal:  J Abnorm Psychol       Date:  2012-05-28

Review 3.  Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.

Authors:  Colin A Depp; Sheena Dev; Lisa T Eyler
Journal:  Psychiatr Clin North Am       Date:  2015-12-11

4.  A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder.

Authors:  Mani N Pavuluri; Alessandra M Passarotti; Stephanie A Parnes; Jacklynn M Fitzgerald; John A Sweeney
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-10       Impact factor: 2.576

5.  Correlates of real world executive dysfunction in bipolar I disorder.

Authors:  Amy T Peters; Andrew D Peckham; Jonathan P Stange; Louisa G Sylvia; Natasha S Hansen; Stephanie Salcedo; Scott L Rauch; Andrew A Nierenberg; Darin D Dougherty; Thilo Deckersbach
Journal:  J Psychiatr Res       Date:  2014-03-02       Impact factor: 4.791

6.  Differential abnormalities of functional connectivity of the amygdala and hippocampus in unipolar and bipolar affective disorders.

Authors:  Brenda E Benson; Mark W Willis; Terence A Ketter; Andrew Speer; Tim A Kimbrell; Peter Herscovitch; Mark S George; Robert M Post
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

7.  Neurological soft signs and cognitive functions: Amongst euthymic bipolar I disorder cases, non-affected first degree relatives and healthy controls.

Authors:  Srikant Sharma; Triptish Bhatia; Sati Mazumdar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2016-04-23

8.  Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression?

Authors:  A G Gildengers; D Chisholm; M A Butters; S J Anderson; A Begley; M Holm; J C Rogers; C F Reynolds; B H Mulsant
Journal:  Psychol Med       Date:  2012-07-30       Impact factor: 7.723

9.  Cognitive deficits in bipolar disorder: from acute episode to remission.

Authors:  J Volkert; M A Schiele; Julia Kazmaier; Friederike Glaser; K C Zierhut; J Kopf; S Kittel-Schneider; A Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-26       Impact factor: 5.270

10.  Neurocognitive function in pediatric bipolar disorder: 3-year follow-up shows cognitive development lagging behind healthy youths.

Authors:  Mani N Pavuluri; Amy West; S Kristian Hill; Kittu Jindal; John A Sweeney
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-03       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.